HHS - Harte-Hanks Inc Stock Price, Fair Value and News

6.99USD-0.10 (-1.41%)Market Closed

Market Summary

USD6.99-0.10

Market Closed

-1.41%

HHS Stock Price

View Fullscreen

HHS RSI Chart

HHS Valuation

Market Cap

51.3M

Price/Earnings (Trailing)

-54.04

Price/Sales (Trailing)

0.27

EV/EBITDA

11.96

Price/Free Cashflow

166.14

HHS Price/Sales (Trailing)

HHS Profitability

EBT Margin

-0.44%

Return on Equity

-4.76%

Return on Assets

-0.84%

Free Cashflow Yield

0.6%

HHS Fundamentals

HHS Revenue

Revenue (TTM)

189.2M

Rev. Growth (Yr)

-3.55%

Rev. Growth (Qtr)

-8.17%

HHS Earnings

Earnings (TTM)

-950.0K

Earnings Growth (Yr)

78.38%

Earnings Growth (Qtr)

91.35%

Breaking Down HHS Revenue

52 Week Range

7.10

(Low)(High)

Last 7 days

0.1%

Last 30 days

-2.7%

Last 90 days

-9.9%

Trailing 12 Months

16.7%

How does HHS drawdown profile look like?

HHS Financial Health

Current Ratio

1.44

HHS Investor Care

Buy Backs (1Y)

3.27%

Diluted EPS (TTM)

-0.12

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	189.2M	0	0	0
2023	204.6M	0	202.9M	198.5M
2022	199.9M	202.0M	204.2M	206.3M
2021	180.1M	187.8M	189.7M	194.6M
2020	207.4M	197.2M	187.1M	176.9M
2019	262.6M	247.6M	235.5M	217.6M
2018	370.2M	345.1M	314.3M	284.6M
2017	399.7M	397.1M	394.1M	383.9M
2016	434.4M	422.6M	411.2M	404.4M
2015	530.3M	499.1M	473.8M	444.2M
2014	560.0M	560.2M	559.3M	553.7M
2013	574.0M	571.3M	565.3M	559.6M
2012	760.4M	700.3M	638.4M	581.1M
2011	811.3M	806.5M	792.7M	811.6M
2010	0	847.0M	833.9M	820.7M
2009	0	0	0	860.1M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Harte-Hanks Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 04, 2024	wyman robert t.	acquired	96,750	7.74	12,500	general counsel
Dec 01, 2023	radoff bradley louis	bought	144,670	7.2335	20,000	-
Nov 29, 2023	radoff bradley louis	bought	68,197	6.8197	10,000	-
Nov 15, 2023	davis kirk a	bought	40,551	7.06601	5,739	chief executive officer
Aug 17, 2023	copeland david l	acquired	89,998	5.55	16,216	-
Aug 17, 2023	griffin john h jr	bought	4,353	5.64669	771	-
Aug 17, 2023	combes genevieve claire	acquired	89,998	5.55	16,216	-
Aug 17, 2023	griffin john h jr	bought	45,698	5.62162	8,129	-
Aug 17, 2023	griffin john h jr	acquired	89,998	5.55	16,216	-

Which funds bought or sold HHS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%
Apr 24, 2024	Krilogy Financial LLC	reduced	-4.37	33,215	654,500	0.05%
Mar 11, 2024	VANGUARD GROUP INC	unchanged	-	85,179	2,065,590	-%
Feb 14, 2024	STATE STREET CORP	unchanged	-	5,264	127,632	-%
Feb 14, 2024	BANK OF AMERICA CORP /DE/	new	-	20.00	20.00	-%
Feb 14, 2024	Man Group plc	added	4.7	42,236	501,367	-%
Feb 14, 2024	WESTERLY CAPITAL MANAGEMENT, LLC	added	1.03	241,409	4,733,310	2.34%
Feb 14, 2024	TWO SIGMA ADVISERS, LP	reduced	-29.89	-66,143	179,935	-%
Feb 14, 2024	TWO SIGMA INVESTMENTS, LP	reduced	-34.37	-89,631	194,459	-%
Feb 14, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	added	10.14	39,164	302,467	0.01%

Are Funds Buying or Selling HHS?

Are funds buying HHS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own HHS

No. of Funds

Unveiling Harte-Hanks Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 22, 2024	westerly capital management, llc	9.66%	697,100	SC 13G/A
Feb 12, 2024	blair william & co/il	9.2%	660,845	SC 13G/A
Feb 14, 2023	westerly capital management, llc	9.57%	691,000	SC 13G/A
Feb 14, 2023	westerly capital management, llc	9.57%	691,000	SC 13G
Feb 10, 2023	blair william & co/il	9.2%	660,839	SC 13G/A
Dec 09, 2022	wipro ltd	1.37%	1e+05	SC 13D/A
Sep 09, 2022	westerly capital management, llc	9.52%	669,800	SC 13G/A
Aug 17, 2022	radoff bradley louis	2.3%	160,000	SC 13D/A
Jul 08, 2022	wipro ltd	12.49%	1,001,658	SC 13D/A
Feb 14, 2022	westerly capital management, llc	16.93%	1,181,000	SC 13G/A

Recent SEC filings of Harte-Hanks Inc

View All Filings

Date Filed	Form Type	Document
May 10, 2024	8-K	Current Report
May 10, 2024	10-Q	Quarterly Report
Apr 04, 2024	DEF 14A	DEF 14A
Apr 01, 2024	10-K	Annual Report
Mar 22, 2024	SC 13G/A	Major Ownership Report
Mar 18, 2024	8-K	Current Report
Mar 04, 2024	4	Insider Trading
Feb 12, 2024	SC 13G/A	Major Ownership Report
Feb 05, 2024	8-K	Current Report
Feb 01, 2024	4	Insider Trading

Peers (Alternatives to Harte-Hanks Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
HON	130.6B	36.9B	1.11%	2.19%	22.81	3.54	2.64%	9.59%
MMM	53.9B	32.7B	5.10%	-3.54%	-7.65	1.65	-2.33%	-229.13%
MID-CAP
MDU	5.2B	4.3B	1.95%	-12.85%	10.92	1.22	-12.81%	27.58%
GFF	3.7B	2.6B	6.04%	143.78%	18.63	1.39	-6.93%	168.08%
SEB	3.2B	9.3B	5.01%	-12.96%	12.22	0.35	-16.12%	-42.64%
VRTV	2.3B	6.1B	0.44%	30.98%	8.49	0.38	-17.09%	-15.90%
SMALL-CAP
CODI	1.7B	2.1B	-8.42%	15.62%	11.89	0.79	3.17%	17.98%
MATW	884.4M	1.9B	0.95%	-23.55%	26.65	0.47	3.63%	150.88%
SPLP	769.8M	1.9B	-2.91%	-12.21%	4.81	0.4	27.14%	16.72%
NNBR	168.5M	483.4M	-20.33%	165.35%	-3.21	0.35	-2.89%	-59.27%
RCMT	162.8M	268.1M	5.53%	62.20%	9.61	0.61	-0.66%	-6.92%

Harte-Hanks Inc News

Latest updates

Harte-Hanks Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-8.2%	45,448,000	49,491,000	47,119,000	47,120,000	54,778,000	53,886,000	51,474,000	49,062,000	51,986,000	49,597,000	49,259,000	43,754,000	47,075,000	47,702,000	41,601,000	46,964,000	52,327,000	51,414,000	54,686,000	59,150,000	70,209,000
Costs and Expenses	-12.9%	45,073,000	51,769,000	44,205,000	46,067,000	51,348,500	50,113,000	44,542,000	45,168,000	49,123,500	45,371,000	47,824,000	44,638,000	47,443,500	46,917,000	47,486,000	45,629,000	51,905,000	55,889,000	61,299,000	70,090,000	74,547,500
S&GA Expenses	29.1%	5,939,000	4,602,000	4,922,000	6,084,000	4,650,000	5,970,000	5,340,000	5,933,000	4,630,000	4,516,000	4,591,000	4,121,000	5,940,500	4,540,000	5,093,000	5,948,000	4,067,000	5,623,000	7,127,000	7,475,000	-
EBITDA Margin	40.9%	0.02	0.01	0.04	0.08	0.10	0.10	0.09	0.11	0.09	0.07	0.04	-0.06	-0.09	-0.08	-0.09	-0.07	-0.09	-0.10	-	-	-
Interest Expenses	26.7%	-11,000	-15,000	-1,000	210,000	-125,000	-84,000	-95,000	-134,000	-258,000	-222,000	-155,000	-268,000	-281,000	-274,000	-298,000	-312,000	-324,000	-330,000	-388,000	-220,000	-262,000
Income Taxes	95.0%	-100,000	-1,985,000	1,912,000	-500,000	-19,790,000	1,200,000	700,000	454,000	229,000	200,000	300,000	600,000	-3,732,500	-53,000	-1,518,000	-11,294,000	913,000	102,000	-52,000	790,000	-7,301,500
Earnings Before Taxes	93.9%	-242,000	-3,946,000	2,530,000	-1,323,000	1,997,000	8,385,000	5,132,000	3,799,000	2,026,000	4,576,000	10,824,000	-1,167,000	-2,707,000	-1,674,000	-7,753,000	-6,176,000	-2,033,000	-5,886,000	-3,855,000	-12,737,000	-5,673,000
EBT Margin	54.2%	0.00	-0.01	0.02	0.07	0.09	0.09	0.08	0.11	0.08	0.06	0.03	-0.07	-0.10	-0.09	-0.11	-0.09	-0.11	-0.12	-	-	-
Net Income	91.4%	-171,000	-1,977,000	618,000	-791,000	21,804,000	7,166,000	4,461,000	3,345,000	1,756,000	4,404,000	10,569,000	-1,758,000	1,044,000	-1,621,000	-6,235,000	5,118,000	-2,946,000	-5,988,000	-3,803,000	-13,527,000	1,639,000
Net Income Margin	36.5%	-0.01	-0.01	0.11	0.16	0.18	0.08	0.07	0.10	0.08	0.08	0.04	-0.05	-0.01	-0.03	-0.05	-0.04	-0.12	-0.09	-	-	-
Free Cashflow	-304.9%	-6,218,000	3,035,000	1,299,000	1,138,000	6,483,000	10,263,000	8,439,000	-2,193,000	3,607,000	-2,718,000	712,000	-6,410,000	2,268,000	-5,337,000	-2,664,000	-4,806,000	1,482,000	-6,301,000	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-7.6%	113	123	111	115	115	120	111	114	111	108	112	114	117	119	115	119	114	110	112	126	134
Current Assets	-11.4%	58.00	65.00	62.00	64.00	62.00	66.00	81.00	84.00	80.00	75.00	82.00	82.00	84.00	86.00	92.00	94.00	83.00	79.00	79.00	88.00	93.00
Cash Equivalents	-34.9%	12.00	18.00	13.00	13.00	13.00	10.00	7.00	11.00	10.00	15.00	16.00	12.00	25.00	34.00	32.00	36.00	29.00	34.00	32.00	39.00	21.00
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net PPE	-5.0%	8.00	9.00	9.00	10.00	10.00	11.00	11.00	9.00	9.00	8.00	7.00	6.00	6.00	6.00	5.00	6.00	8.00	8.00	9.00	10.00	12.00
Goodwill	0%	2.00	2.00	2.00	2.00	2.00	2.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities	-9.2%	93.00	103	90.00	94.00	94.00	101	114	122	122	123	141	147	162	163	154	159	149	150	143	151	156
Current Liabilities	-16.5%	40.00	48.00	39.00	40.00	38.00	44.00	46.00	42.00	45.00	42.00	42.00	47.00	53.00	47.00	50.00	53.00	44.00	46.00	45.00	50.00	55.00
Long Term Debt	-	-	-	-	-	-	-	-	10.00	5.00	5.00	13.00	13.00	18.00	22.00	20.00	22.00	19.00	19.00	19.00	19.00	19.00
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	9.00	5.00	7.00	5.00	-	-	-	-	-
LT Debt, Non Current	-	-	-	-	-	-	-	-	10.00	5.00	5.00	13.00	13.00	18.00	22.00	20.00	22.00	19.00	19.00	19.00	19.00	19.00
Shareholder's Equity	0.5%	20.00	20.00	21.00	21.00	21.00	19.00	-	-	-	-24.71	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	0.0%	845	845	847	846	846	846	826	819	814	811	809	805	794	796	795	797	803	798	801	807	811
Additional Paid-In Capital	-3.0%	153	158	160	187	197	218	220	273	278	291	290	337	367	383	394	410	418	447	447	452	452
Accumulated Depreciation	1.9%	37.00	37.00	38.00	37.00	45.00	44.00	48.00	52.00	53.00	53.00	65.00	66.00	70.00	70.00	75.00	109	122	125	131	131	130
Shares Outstanding	0.2%	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	6.00	6.00	6.00	6.00	-	-
Float	-	-	-	-	34.00	-	-	-	71.00	-	-	-	30.00	-	-	-	18.00	-	-	-	12.00	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-230.3%	-5,692	4,367	1,523	2,883	1,704	6,540	12,390	10,626	-764	4,175	-1,224	961	-5,675	3,593	-3,988	-3,471	-3,974	2,722	-5,952	18,198	-2,871
Share Based Compensation	156.7%	552	215	161	502	540	579	926	562	288	377	330	540	222	174	272	103	215	335	315	274	150
Cashflow From Investing	36.9%	-525	-832	-222	-690	-565	-5,807	-2,127	-2,187	-1,372	-523	-1,494	-148	-735	-1,292	-1,271	2,424	-636	-955	-349	-190	-1,101
Cashflow From Financing	-73.3%	-149	-86.00	-818	-2,047	-265	-9,399	-10,929	4,790	-282	-8,568	-314	-4,332	-199	-199	-522	8,273	-239	-346	-301	-327	4,060
Buy Backs	-	-	-	491	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

HHS Income Statement

2023-12-31

Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Operating revenue	$ 191,492	$ 206,278
Operating expenses
Labor	97,968	104,620
Production and distribution	59,568	61,930
Advertising, selling, general and administrative	20,673	21,893
Restructuring expense	5,687	0
Depreciation and amortization expense	4,237	2,728
Total operating expenses	188,133	191,171
Operating income (loss)	3,359	15,107
Other expense (income), net
Interest (income) expense, net	(135)	438
Other expense (income), net	5,413	(4,644)
Total other expense (income), net	5,278	(4,206)
(Loss) income before income taxes	(1,919)	19,313
Income tax benefit	(349)	(17,463)
Net (loss) income	(1,570)	36,776
Less: Loss from redemption of Preferred stock	0	1,380
Less: Preferred stock dividends	0	0
Less: Earnings attributable to participating securities	0	0
(Loss) income attributable to common stockholders	$ (1,570)	$ 35,396
(Loss) earnings per common share
Basic (in dollars per share)	$ (0.21)	$ 4.98
Diluted (in dollars per share)	$ (0.21)	$ 4.75
Weighted-average shares used to compute income per share attributable to common shares
Basic (in shares)	7,310	7,101
Diluted (in shares)	7,310	7,457
Comprehensive income, net of tax
Net (loss) income	$ (1,570)	$ 36,776
Adjustment to pension liability	1,664	10,274
Foreign currency translation adjustments	2,548	(5,248)
Total other comprehensive income, net of tax	4,212	5,026
Comprehensive income	$ 2,642	$ 41,802

HHS Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 18,364	$ 10,364
Accounts receivable (less allowance of $474 and $163 at December 31, 2023 and 2022)	34,313	39,700
Contract assets and unbilled accounts receivable	7,935	8,202
Prepaid expenses	1,915	2,176
Prepaid income tax and income tax receivable	1,758	4,262
Other current assets	928	1,607
Total current assets	65,213	66,311
Net property, plant and equipment	8,855	10,523
Right-of-use assets	25,417	19,169
Other assets
Intangible assets, net	2,820	3,540
Goodwill	1,926	2,398
Deferred tax assets, net	17,268	16,306
Other long-term assets	1,258	1,737
Total other assets	23,272	23,981
Total assets	122,757	119,984
Current liabilities
Accounts payable and accrued expenses	23,176	22,465
Accrued payroll and related expenses	5,615	6,679
Deferred revenue and customer advances	3,195	4,590
Customer postage and program deposits	1,815	1,223
Other current liabilities	9,495	2,862
Short-term lease liabilities	4,815	5,747
Total current liabilities	48,111	43,566
Long-term lease liabilities	23,691	16,575
Other long-term liabilities	1,928	3,263
Total liabilities	102,900	101,176
Stockholders’ equity
Common stock, $1 par value, 25,000,000 shares authorized,12,221,484 shares issued, 7,224,718 and 7,402,614 shares outstanding at December 31, 2023 and 2022, respectively	12,221	12,221
Additional paid-in capital	157,889	218,411
Retained earnings	844,920	846,490
Less treasury stock, 4,996,766 shares at cost at December 31, 2023 and 4,818,870 shares at cost at December 31, 2022	(951,083)	(1,010,012)
Accumulated other comprehensive loss	(44,090)	(48,302)
Total stockholders’ equity	19,857	18,808
Total liabilities and stockholders’ equity	122,757	119,984
Qualified Plan
Current liabilities
Pension liabilities	10,540	18,674
Nonqualified Plan
Current liabilities
Pension liabilities	$ 18,630	$ 19,098

About Harte-Hanks Inc

Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company provides strategic guidance to help clients to plan and execute omni-channel marketing programs; audience identification, profiling, segmentation and prioritization, predictive modeling, and data strategy services; data hygiene and cleansing services; print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice services; Website and app development, e-commerce enablement, database building and management, platform architecture creation, and marketing automation services; and outsourcing marketing operations solutions. It also offers customer experience management services comprising interact and resolve consumer concerns across hardware and software platforms, healthcare benefit plans, and recalls or a myriad of other customer service issues; CRM and digital transformation solutions to create meaningful customer interactions by connecting content between agent or AI-driven interfaces and web-based self-help tools and community forums; and intelligence-based B2B solutions that understand audiences and their behaviors, and then inspire and drive action to deliver results. In addition, the company provides product, print-on-demand, and mail fulfillment solutions, such as printing on demand, managing product recalls, and distributing literature and promotional products; custom solutions to engage audiences, target customers, support conferences, and appreciate employees; and third-party logistics and freight optimization services. It primarily serves B2B, consumer brand, financial services, retail, and healthcare vertical markets. The company was founded in 1923 and is headquartered in Chelmsford, Massachusetts.

CEO	Mr. Kirk A. Davis
WEBSITE	hartehanks.com
INDUSTRY	Conglomerates
EMPLOYEES	1881

Harte-Hanks Inc Frequently Asked Questions

What is the ticker symbol for Harte-Hanks Inc? What does HHS stand for in stocks?

HHS is the stock ticker symbol of Harte-Hanks Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Harte-Hanks Inc (HHS)?

As of Thu May 09 2024, market cap of Harte-Hanks Inc is 51.34 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HHS stock?

You can check HHS's fair value in chart for subscribers.

What is the fair value of HHS stock?

You can check HHS's fair value in chart for subscribers. The fair value of Harte-Hanks Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Harte-Hanks Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HHS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Harte-Hanks Inc a good stock to buy?

The fair value guage provides a quick view whether HHS is over valued or under valued. Whether Harte-Hanks Inc is cheap or expensive depends on the assumptions which impact Harte-Hanks Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HHS.

What is Harte-Hanks Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 09 2024, HHS's PE ratio (Price to Earnings) is -32.7 and Price to Sales (PS) ratio is 0.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HHS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Harte-Hanks Inc's stock?

In the past 10 years, Harte-Hanks Inc has provided -0.218 (multiply by 100 for percentage) rate of return.